ASSESSMENT OF THE INFLUENCE OF SUBACUTE PHENOBARBITONE ADMINISTRATIONON MULTI-TISSUE CELL-PROLIFERATION IN THE RAT USING BROMODEOXYURIDINEIMMUNOCYTOCHEMISTRY
Hb. Jones et Nab. Clarke, ASSESSMENT OF THE INFLUENCE OF SUBACUTE PHENOBARBITONE ADMINISTRATIONON MULTI-TISSUE CELL-PROLIFERATION IN THE RAT USING BROMODEOXYURIDINEIMMUNOCYTOCHEMISTRY, Archives of toxicology, 67(9), 1993, pp. 622-628
The effects of daily administration of phenobarbitone on the mitotic r
ates of several tissues were investigated by bromodeoxyuridine (BrdU)
immunocytochemistry. Phenobarbitone (80 mg/kg per day) was dosed to AP
Wistar male rats for up to 7 days and BrdU (10 mg/ml) was given by in
fusion at a rate of 10 mul/h via subcutaneously implanted osmotic mini
pumps for 2 days prior to necropsy on days 1, 2, 3, 5 and 7. BrdU-labe
lled nuclei were visualised by peroxidase-antiperoxidase immunocytoche
mistry and counts of the numbers of labelled cells (labelling index, L
I%) made from at least 1000 cells per tissue section(s). The LIs of se
veral tissues (testis, adrenal cortex and medulla, kidney distal convo
luted tubule and exocrine pancreas) showed no statistical difference b
y comparison with controls. Several tissues exhibited characteristic r
esponses to phenobarbitone administration. Pituitary and endocrine pan
creas LIs were decreased while those of thyroid, liver and kidney prox
imal convoluted tubule were increased. The pattern of LI increase was
unique to each tissue with liver (median and lateral lobes) increased
two-fold on day 3 and returning to control levels thereafter while kid
ney proximal tubule LI rose gradually with time and remained elevated
on day 7. Thyroid LI on day 1 was almost double that of day 0 control
and increased steadily thereafter. These data illustrate the varied re
sponses of different tissues to phenobarbitone exposure, namely, depre
ssion and stimulation of mitosis. The causation of these functional ch
anges is discussed in relation to direct and indirect effects on funct
ional parameters, especially enzyme induction, alterations in hormonal
and growth factor status and receptor regulation.